Violaine Havelange

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Journal of cellular and molecular medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Hematology (Amsterdam, Netherlands)

This page only lists publications with an associated author ORCID identifier.

Publications

Violaine Havelange, Stefan N Constantinescu
The 2 faces of ERK2 in MPNs. Blood 140 (4) (2022)
Timothy Devos, Dominik Selleslag, Nikki Granacher, Violaine Havelange, Fleur Samantha Benghiat
Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Tim Grob, Mathijs Arnoud Sanders, Christian M Vonk, Franҫois G Kavelaars, Melissa Rijken, Diana W Hanekamp, Patrycja L Gradowska, Jacqueline Cloos, Yngvar Fløisand, Marinus van Marwijk Kooy, Markus Gabriel Manz, Gert J Ossenkoppele, Lidwine W Tick, Violaine Havelange, Bob Löwenberg, Mojca Jongen-Lavrencic, Peter J M Valk
Prognostic Value of FLT3 -Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Emeline Bollaert, Melissa Claus, Virginie Vandewalle, Sandrine Lenglez, Ahmed Essaghir, Jean-Baptiste Demoulin, Violaine Havelange
MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin. International journal of molecular sciences 22 (10) (2021)
Virginie Vandewalle, Ahmed Essaghir, Emeline Bollaert, Sandrine Lenglez, Carlos Graux, Hélène Schoemans, Pascale Saussoy, Lucienne Michaux, Peter J M Valk, Jean-Baptiste Demoulin, Violaine Havelange
miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2. Journal of cellular and molecular medicine 25 (1) (2020)